港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

抗疫概念

836.778

-19.332-2.26%

涨家数：2

跌家数：14

平家数：1

市盈率：- -

高：862.634

开：856.520

低：832.621

收：856.110

成交量：3.13亿

成交额：21.85亿

市值：5,681.83亿

流通市值：4,664.22亿

数据加载中...

总览新闻资讯

医药股走低恒生生物科技指数跌2.48% 映恩生物-B（09606）大跌31.05%

港股异动 | 国药控股(01099.HK)再涨近3% 三季度纯利略优于市场预期严谨费用控制抵销收入及毛利持续压力

大行评级｜花旗：微升国药控股目标价至20.5港元，维持“买入”评级

阿里健康(00241)出现大手卖出130万股，成交价$2.81，涉资365.3万

阿斯达克财经

港股异动 | 礼邦医药-B(09637)早盘涨超10% 合作伙伴R1已于ASN肾脏周展示AP306全球IIb期多区域临床试验设计壁报

智通财经网

中生制药(01177.HK)两款乙肝新药获纳入突破性治疗药物程序

阿斯达克财经

【湾区早参】广州前三季度社会消费品零售总额8363亿元；深圳算力相关四大行业中长期贷款年内新增破千亿

港股公告掘金 | 联易融科技-W前三季度收入及收益取得显著增长持续推进AI战略转型与全球化布局

中国生物制药：两款乙肝创新药获纳入突破性治疗药物程序

中国生物制药(01177.HK)：TQ-A3334“TLR7激动剂”及TQA3605“核心蛋白变构调节剂”获CDE纳入突破性治疗药物程序

石药集团公布安尼妥单抗治疗HER2阳性晚期胃癌III期OS更新结果

平安好医生三季度报告：净利大增35%，股价却创新低

A股晚间热点 | 利好来了！4400亿医药巨头上调业绩指引多家龙头净利大增

智通财经网

石药集团(01093.HK)：安尼妥单抗联合注射用多西他赛(白蛋白结合型)(HB1801)用于HER2阳性晚期乳腺癌一线治疗的III期临床研究结果于2026年ESMO年会上以优选口头报告形式公布

石药集团(01093)：安尼妥单抗用于治疗HER2阳性晚期胃癌╱胃食管结合部腺癌的III期临床研究总生存期(OS)更新结果于2026年ESMO年会上以快速口头报告形式公布

石药集团：Anbenitamab治疗HER2阳性晚期胃癌III期试验OS结果更新

劲方医药-B(02595.HK)10月26日斥资240.25万港元回购8.58万股

歌礼制药-B(01672)10月26日斥资约55.88万港元回购10万股

上海市政府发布一组人事任免信息：13名干部履新职

中金：予平安好医生(01833.HK)目标价8.3港元较当前股价有49.3%上行空间

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1515/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":836.77795,"timestamp":1793088499319,"preClose":856.1097,"halted":0,"volume":312917297,"delay":0,"changeRate":-0.022581,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-19.331726,"latestTime":"10-27 16:00:00","open":856.5203,"high":862.6343,"low":832.62146,"amount":2185460884,"amplitude":0.035057,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793151000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1793064600000,1793073600000],[1793077200000,1793088000000]],"pbRate":1.329847,"peRate":16.832058,"turnoverRate":0.003805,"increases":3,"decrements":13,"flats":1,"marketCap":568183074048,"floatMarketCap":466422399424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":862.6343,"amplitude":0.035057,"preClose":856.1097,"low":832.62146,"pbRate":"1.329847","latestPrice":836.77795,"volume":312917297,"delay":0,"open":856.5203,"prevYearClose":1190.107,"prevWeekClose":859.77,"prevMonthClose":925.469,"prevQuarterClose":925.469,"fiveDayClose":905.671,"twentyDayClose":893.286,"sixtyDayClose":925.972,"secType":"PLATE","market":"HK","turnoverRate":0.003805,"peRate":16.832058,"marketCap":568183074048,"floatMarketCap":466422399424,"timestamp":1793088499319,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":2,"down":14,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2678140953","title":"医药股走低 恒生生物科技指数跌2.48% 映恩生物-B（09606）大跌31.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678140953","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678140953?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 14:18","pubTimestamp":1793081937,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股走低，恒生生物科技指数大幅跌2.48%。成分股中，映恩生物-B跌31.05%，亚盛医药跌6.70%，科伦博泰生物跌5.96%，三生制药跌5.10%，石药集团跌4.25%，康方生物跌3.63%，中国生物制药跌3.26%，翰森制药跌3.10%，百济神州跌3.03%。近两个月连锁药房密集推出股权激励，驱动板块逻辑从“政策博弈”转向“业绩锚定”。","market":"other","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994559","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328277881.USD","LU0348783233.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1593","HK0000500386.USD","01093","LU1961090484.USD","BK1583","06990","01530","LU0314109678.HKD","LU0315179316.USD","LU0561508036.HKD","SG9999004220.SGD","IE00BZ08YR35.GBP","LU0588546209.SGD","LU0634319403.HKD","IE0008368742.USD","159938","LU1226287529.USD","LU0348766576.USD","LU0501845795.SGD","LU2488822045.USD","LU0417516902.SGD","LU1226287792.SGD","03692","06855","09606","BK1588","09939","LU1969619763.USD","LU0140636845.USD","KURE","LU0417516738.SGD","06160","09926","LU2039709279.SGD","IE0008369823.USD","LU2476274720.SGD","LU1226287875.USD","LU0348827113.USD","01177","LU1993786604.SGD","LU0348784397.USD","BK1515","LU1719994722.HKD","LU0880133367.SGD","HK0000252152.HKD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678147853","title":"港股异动 | 国药控股(01099.HK)再涨近3% 三季度纯利略优于市场预期 严谨费用控制抵销收入及毛利持续压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2678147853","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678147853?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 13:39","pubTimestamp":1793079555,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1500","LU1115378108.SGD","BK1197","01099","BK1515","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678984149","title":"大行评级｜花旗：微升国药控股目标价至20.5港元，维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2678984149","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678984149?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 10:55","pubTimestamp":1793069725,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1515","01099","BK1500","LU0640798160.USD","LU1115378108.SGD","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678167149","title":"阿里健康(00241)出现大手卖出130万股，成交价$2.81，涉资365.3万","url":"https://stock-news.laohu8.com/highlight/detail?id=2678167149","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678167149?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 10:39","pubTimestamp":1793068740,"startTime":"0","endTime":"0","summary":"[大手成交]阿里健康(00241)在上午10:39出现大手卖出，成交量为130万，成交价为港币$2.81，涉资365.3万。至目前为止，股价跌1.054%，今日最高价为$2.875，而最低价为$2.81，总成交量为1.361千万股，总成交金额港币$3.85千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2610274272/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2610274272/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1247","BK1515","HK0000165453.HKD","BK1610","BK1501","BK1584","00241","BK1615","BK1502","BK1571","BK1617","BK1189","BK1589","BK1591","BK1142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678146039","title":"港股异动 | 礼邦医药-B(09637)早盘涨超10% 合作伙伴R1已于ASN肾脏周展示AP306全球IIb期多区域临床试验设计壁报","url":"https://stock-news.laohu8.com/highlight/detail?id=2678146039","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678146039?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 10:32","pubTimestamp":1793068352,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼邦医药-B早盘涨超10%。该项全球IIb期多区域临床试验由礼邦医药与R1共同申办，目前正在美国及中国的多个临床中心开展。公司已于2026年7月21日就该试验完成首例受试者随机化并给药进行公告，目前美国及中国临床中心的受试者招募正在进行中，预计试验将于2027年第二季度完成，顶线数据将在适当时候公布。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","PSYK","IBBJ","IBBQ","MDTX","BMED","BK1161","BK1191","09939","KCAI","VXUS","159938","09637","BK1515","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678145605","title":"中生制药(01177.HK)两款乙肝新药获纳入突破性治疗药物程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2678145605","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678145605?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 09:31","pubTimestamp":1793064660,"startTime":"0","endTime":"0","summary":"中生制药公布，附属公司正大天晴自主研发的国家1类创新药TQ-A3334及TQA3605，均已获国家药监局药品审评中心纳入突破性治疗药物程序。两款创新药分别针对慢性乙型肝炎治疗中尚未满足的功能性治愈与低病毒血症两大需求。其中TQ-A3334为口服高选择性TLR7激动剂，是次获纳入突破性治疗药物程序，主要基于其二期临床数据在关键疗效指标上展现实质性改善潜力，相关研究结果已入选2026年美国肝病研究学会最新突破摘要，并将以口头报告形式公布。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1551187/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1551187/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00BZ08YR35.GBP","BK1515","HK0000165453.HKD","BK1574","IE00BZ08YT58.USD","01477","BK1589","BK1521","IE00BZ08YS42.EUR","BK1191","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678367145","title":"【湾区早参】广州前三季度社会消费品零售总额8363亿元；深圳算力相关四大行业中长期贷款年内新增破千亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2678367145","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678367145?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 09:15","pubTimestamp":1793063729,"startTime":"0","endTime":"0","summary":"前三季度，全市社会消费品零售总额8363亿元，同比增长2.5%，高于全国、全省，在一线城市中保持领先。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MzQxNzMxMDUyMTQyMzY4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQxNzMxMDUyMTQyMzY4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994493","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","SGDM","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1149","LU1223083913.SGD","CNHmain","IE00BZ08YS42.EUR","BK4017","LU1223082519.USD","01177","BK1515","GDXJ","CYB","ORR","BK1521","LU1223082196.USD","CDE","BK1191","03268","XME","IE00BZ08YT58.USD","UCmain","BK1170","03228","SIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678143691","title":"港股公告掘金 | 联易融科技-W前三季度收入及收益取得显著增长 持续推进AI战略转型与全球化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2678143691","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678143691?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 09:05","pubTimestamp":1793063120,"startTime":"0","endTime":"0","summary":"重大事项：英硅智能(03696)于ESMO 2026公布生成式AI赋能设计的ISM6331治疗间皮瘤及其他实体瘤的首次人体临床试验初步积极数据中国生物制药(01177)：TQ-A3334“TLR7激动剂”及TQA3605“核心蛋白变构调节剂”获CDE纳入突破性治疗药物程序瓦普思瑞元宇宙(08093)拟获远望谷(002161.SZ)折让约25.3%提全购要约石药集团(01093)：安尼妥单抗联合注射","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1152091754.HKD","BK1589","08093","CHAT","01093","09959","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU1008478684.HKD","VXUS","IE00BZ08YT58.USD","BK1518","LU0880133367.SGD","ARTY","BK1516","LU2039709279.SGD","BK1109","LU1226287875.USD","BK4588","LU1328277881.USD","LU1951186391.HKD","BK1521","BK1515","LU1152091168.USD","KURE","SG9999004220.SGD","LU1226288253.USD","QTOC","VTHR","BK1587","LU0072913022.USD","IE0008368742.USD","LU0140636845.USD","BK4585","BK1141","03696","LU0326950275.SGD","AIPO","AGIX","KCAI","HK0000165453.HKD","LU0501845795.SGD","BK1575","LU1226288170.HKD","IE00B031HY20.USD","IE0008369823.USD","LU1226287529.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678011026","title":"中国生物制药：两款乙肝创新药获纳入突破性治疗药物程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2678011026","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678011026?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 08:09","pubTimestamp":1793059754,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["HK0000165453.HKD","06978","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1589","BK1574","01177","BK1515","IE00BZ08YR35.GBP","BK1161","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678110166","title":"中国生物制药(01177.HK)：TQ-A3334“TLR7激动剂”及TQA3605“核心蛋白变构调节剂”获CDE纳入突破性治疗药物程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2678110166","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678110166?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 08:02","pubTimestamp":1793059346,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1521","IE00BZ08YS42.EUR","BK1589","BK1515","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","01177","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148572720","title":"石药集团公布安尼妥单抗治疗HER2阳性晚期胃癌III期OS更新结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1148572720","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148572720?lang=zh_cn&edition=fundamental","pubTime":"2026-10-27 01:10","pubTimestamp":1793034654,"startTime":"0","endTime":"0","summary":"10月26日 - 石药集团（1093.HK）：*安尼妥单抗用于HER2阳性晚期胃癌的III期总生存期（OS）更新结果*安尼妥单抗组未出现治疗相关死亡；对照组为5例*更多公司报道：1093.HK","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","HK0000165453.HKD","LU1993786604.SGD","LU1226287792.SGD","LU1960683339.HKD","LU1951186391.HKD","LU1226287875.USD","LU1152091168.USD","KURE","LU1226287529.USD","IE00BZ08YT58.USD","LU1807302812.USD","LU1152091754.HKD","LU1008478684.HKD","LU0072913022.USD","LU1226288253.USD","BK1515","LU0326950275.SGD","IE00BZ08YS42.EUR","LU0315179316.USD","IE00B031HY20.USD","BK1191","LU0140636845.USD","LU1328277881.USD","SG9999004220.SGD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","LU0501845795.SGD","LU0880133367.SGD","LU1813983027.USD","BK1521","LU0067412154.USD","LU1226288170.HKD","01093","IE0008369823.USD","IE0008368742.USD","LU0314109678.HKD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678194853","title":"平安好医生三季度报告：净利大增35%，股价却创新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2678194853","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678194853?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 22:31","pubTimestamp":1793025060,"startTime":"0","endTime":"0","summary":"来源：金观社10月22日晚间，平安健康医疗科技有限公司披露2026年前三季度业绩，实现总收入35.08亿元，同比下降5.8%；净利润2.48亿元，同比增长35%。中国好医生在公告中解释为“主动优化收入结构、压降低毛利业务”。此外，平安好医生的四成收入来自平安系。中期数据显示，2026年上半年公司向平安系关联方提供产品及服务合计10.48亿元，同比增长约五成，占总收入比例超过四成且仍在上升。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-10-26/doc-iniwqpfh2368076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","01833","BK1247","BK1142","BK1571","BK1615","BK1219","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678819481","title":"A股晚间热点 | 利好来了！4400亿医药巨头上调业绩指引 多家龙头净利大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2678819481","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678819481?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 22:30","pubTimestamp":1793025013,"startTime":"0","endTime":"0","summary":"10月26日晚间，药明康德公告，第三季度净利同比增长137%，进一步上调2026年全年业绩指引。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20261026/20261026222228_16764.png?x-oss-process=image/format,jpg/quality,q_60&image_source=0","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20261026/20261026222228_16764.png?x-oss-process=image/format,jpg/quality,q_60&image_source=0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512825.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03130","02827","09939","83130","02822","02843","07233","BK1161","03188","83188","82823","82846","BK1574","BK1610","BK1147","399300","159938","159982","02846","BK1515","82822","82843","02823"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678160931","title":"石药集团(01093.HK)：安尼妥单抗联合注射用多西他赛(白蛋白结合型)(HB1801)用于HER2阳性晚期乳腺癌一线治疗的III期临床研究结果于2026年ESMO年会上以优选口头报告形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2678160931","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678160931?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 19:32","pubTimestamp":1793014354,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0880133367.SGD","LU1152091168.USD","LU0072913022.USD","LU0314109678.HKD","IE0008368742.USD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU1152091754.HKD","LU1951186391.HKD","LU1993786604.SGD","BK1191","IE00B031HY20.USD","LU2039709279.SGD","LU0067412154.USD","LU0315179316.USD","LU0326950275.SGD","BK1515","SG9999004220.SGD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","HK0000165453.HKD","IE00B543WZ88.USD","LU1960683339.HKD","LU1226288170.HKD","LU1813983027.USD","LU1008478684.HKD","LU0140636845.USD","01093","LU1226288253.USD","IE0008369823.USD","LU1807302812.USD","IE00BZ08YS42.EUR","LU1226287529.USD","LU1226287792.SGD","KURE","LU1328277881.USD","BK1521","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678167005","title":"石药集团(01093)：安尼妥单抗用于治疗HER2阳性晚期胃癌╱胃食管结合部腺癌的III期临床研究总生存期(OS)更新结果于2026年ESMO年会上以快速口头报告形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2678167005","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678167005?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 19:26","pubTimestamp":1793013996,"startTime":"0","endTime":"0","summary":"安尼妥单抗组未发生治疗相关死亡事件，而对照组报告了5例治疗相关死亡事件。整体而言，安尼妥单抗组的安全性特征良好且风险可控。本次2026ESMO年会公布的OS更新数据进一步证实，安尼妥单抗联合化疗用于HER2阳性晚期GC/GEJA患者的二线及以上治疗，兼具短期缩瘤与长期生存的显著获益，且安全性整体可控，有望重塑HER2阳性晚期GC/GEJA的临床治疗格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1807302812.USD","LU1226287875.USD","IE0008369823.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","LU0072913022.USD","LU1008478684.HKD","LU1993786604.SGD","LU0501845795.SGD","LU1226288253.USD","IE00BZ08YT58.USD","LU0140636845.USD","01093","IE00B031HY20.USD","KURE","LU0880133367.SGD","LU1152091168.USD","IE0008368742.USD","LU1328277881.USD","LU1813983027.USD","LU0315179316.USD","LU1226287792.SGD","HK0000165453.HKD","BK1191","LU1960683339.HKD","SG9999004220.SGD","IE00B543WZ88.USD","BK1515","LU2039709279.SGD","BK1521","IE00BZ08YR35.GBP","LU1226287529.USD","LU1152091754.HKD","LU0326950275.SGD","LU0314109678.HKD","LU0067412154.USD","LU1226288170.HKD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139486481","title":"石药集团：Anbenitamab治疗HER2阳性晚期胃癌III期试验OS结果更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1139486481","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139486481?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 19:25","pubTimestamp":1793013910,"startTime":"0","endTime":"0","summary":"石药集团公布Anbenitamab用于HER2阳性晚期胃癌的III期临床试验总生存期（OS）最新结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU0067412154.USD","LU1152091168.USD","LU0314109678.HKD","LU1951186391.HKD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU2039709279.SGD","IE00B031HY20.USD","LU1993786604.SGD","LU1008478684.HKD","01093","LU1960683339.HKD","LU0501845795.SGD","LU1226287875.USD","SG9999004220.SGD","BK1521","LU0326950275.SGD","LU1226287529.USD","LU0072913022.USD","LU1813983027.USD","LU0315179316.USD","LU0140636845.USD","IE0008369823.USD","LU1226288170.HKD","IE00BZ08YR35.GBP","LU1807302812.USD","IE00BZ08YT58.USD","IE00B543WZ88.USD","LU1226287792.SGD","HK0000165453.HKD","LU1152091754.HKD","BK1515","LU0880133367.SGD","LU1328277881.USD","KURE","LU1226288253.USD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678116451","title":"劲方医药-B(02595.HK)10月26日斥资240.25万港元回购8.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678116451","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678116451?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 18:24","pubTimestamp":1793010262,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09939","02595","BK1574","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678164815","title":"歌礼制药-B(01672)10月26日斥资约55.88万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678164815","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678164815?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 18:21","pubTimestamp":1793010066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2026年10月26日该公司斥资约55.88万港元回购10万股，回购价格为每股5.47至5.84港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1191","BK1161","01477","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678816267","title":"上海市政府发布一组人事任免信息：13名干部履新职","url":"https://stock-news.laohu8.com/highlight/detail?id=2678816267","media":"文汇报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678816267?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 18:09","pubTimestamp":1793009340,"startTime":"0","endTime":"0","summary":"市政府近日发布一组人事任免信息任命徐文东同志为复旦大学上海医学院副院长；免去朱同玉同志的复旦大学上海医学院副院长职务。任命林艺同志为中国（上海）自由贸易试验区临港新片区管理委员会专职副主任。任命马雪波同志为上海市公安局副局长。萧烨璎同志任上海演艺有限公司董事长；王磊卿同志任上海演艺有限公司总裁；冯芳、谷好好同志任上海演艺有限公司副总裁。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-10-26/doc-iniwqarp9238726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00241","BK1501","BK1247","BK1584","HK0000165453.HKD","BK1142","BK1515","BK1591","BK1189","BK1502","BK1610","BK1571","BK1617","BK1589","BK1615"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678273163","title":"中金：予平安好医生(01833.HK)目标价8.3港元 较当前股价有49.3%上行空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2678273163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678273163?lang=zh_cn&edition=fundamental","pubTime":"2026-10-26 16:50","pubTimestamp":1793004607,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1615","BK1515","BK1571","BK1617","01833","BK1247","BK1219","BK1142"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}